New York, Feb 21, 2026, 13:06 EST — The market has shut its doors.

• The stock wrapped up Friday off 1.8%, closing at $242.49.
• J&J is lining up a possible sale of DePuy Synthes, Reuters said, with the deal value potentially exceeding $20 billion.
• J&J pushed out fresh long-term data for Tremfya this Saturday, dropping the update before ECCO 2026. Investors are zeroed in on what management says in early March, and again on April 14.

Johnson & Johnson is weighing a sale of its DePuy Synthes orthopedics division that could fetch more than $20 billion, according to a source familiar with the situation, speaking to Reuters on Thursday. The company hasn’t commented yet. This potential sale marks a pivot from J&J’s…